Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B02a7c07f0590a435c05cfb313d9873b9> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B02a7c07f0590a435c05cfb313d9873b9 NCIT_P378 "NCI" @default.
- B02a7c07f0590a435c05cfb313d9873b9 type Axiom @default.
- B02a7c07f0590a435c05cfb313d9873b9 annotatedProperty IAO_0000115 @default.
- B02a7c07f0590a435c05cfb313d9873b9 annotatedSource NCIT_C150511 @default.
- B02a7c07f0590a435c05cfb313d9873b9 annotatedTarget "Genetically engineered human allogeneic T-lymphocytes that are transduced with a retroviral vector encoding a T-cell receptor (TCR) specific for the cancer/testis antigen NY-ESO-1, with potential antineoplastic activity. Upon isolation, transduction, expansion ex vivo and introduction into the patient, the allogeneic T-lymphocytes expressing NY-ESO-1-C259-specific TCR specifically target and bind to NY-ESO-1-overexpressing tumor cells. This may result in the specific cytotoxic T-lymphocyte (CTL) killing of NY-ESO-1-positive cancer cells. NY-ESO-1, a tumor-associated antigen (TAA), is expressed in normal testis and on the surface of various tumor cell types." @default.